Cellerant Therapeutics, Initiates a P I/II Acute Leukemia Clinical Trial of CLT-008
March 28th, 2011
No comments
CLT-008, an allogeneic cell-based therapy, is under development to provide hematopoietic support following high-dose chemotherapy or radiation exposure Read more…
